rs200203460
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_030813.6(CLPB):c.1249C>T(p.Arg417*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000882 in 1,461,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_030813.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
- 3-methylglutaconic aciduria, type VIIBInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- neutropenia, severe congenital, 9, autosomal dominantInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_030813.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CLPB | NM_030813.6 | MANE Plus Clinical | c.1249C>T | p.Arg417* | stop_gained | Exon 11 of 17 | NP_110440.1 | ||
| CLPB | NM_001258392.3 | MANE Select | c.1159C>T | p.Arg387* | stop_gained | Exon 10 of 16 | NP_001245321.1 | ||
| CLPB | NM_001258394.3 | c.1114C>T | p.Arg372* | stop_gained | Exon 12 of 18 | NP_001245323.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CLPB | ENST00000294053.9 | TSL:1 MANE Plus Clinical | c.1249C>T | p.Arg417* | stop_gained | Exon 11 of 17 | ENSP00000294053.3 | ||
| CLPB | ENST00000538039.6 | TSL:2 MANE Select | c.1159C>T | p.Arg387* | stop_gained | Exon 10 of 16 | ENSP00000441518.1 | ||
| CLPB | ENST00000538021.5 | TSL:1 | n.176C>T | non_coding_transcript_exon | Exon 3 of 9 | ENSP00000445180.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000279 AC: 7AN: 251226 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000882 AC: 129AN: 1461804Hom.: 0 Cov.: 30 AF XY: 0.0000963 AC XY: 70AN XY: 727212 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
3-methylglutaconic aciduria, type VIIB Pathogenic:4Other:1
This sequence change creates a premature translational stop signal (p.Arg417*) in the CLPB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLPB are known to be pathogenic (PMID: 25597510, 28687938). This variant is present in population databases (rs200203460, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with 3-methylglutaconic aciduria (PMID: 25597510, 25597511, 27290639, 28687938). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 187786). For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:2
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 28554332, 25473036, 28687938, 33517393, 31345219, 27290639, 25597511, 25597510, 36074910, 34782754)
3-methylglutaconic aciduria, type VIIB;C5676954:Neutropenia, severe congenital, 9, autosomal dominant;C5676967:3-methylglutaconic aciduria, type VIIA Pathogenic:1
Premature ovarian insufficiency;C0853697:Decreased total neutrophil count Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at